Cutting mRNA Research Could Be Our Deadliest Mistake Yet

Thanks to pioneers like Nobel Laureates Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, PhD, an adjunct professor of Neurosurgery, the United States has been at the forefront of mRNA vaccine development, with promising research underway for other diseases such as cancer. But the Department of Health and Human Services (HHS) announcement that it will wind down funding for mRNA vaccine development stands to stagnate research that has the potential to save millions of lives around the world.